Skip to main content

Table 2 Laboratory investigation findings of the patient

From: An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review

Laboratory examination

Patient

Reference range

Hematology and coagulation assays

White blood cell (× 109/L)

6.37

8–10

Neutrophils (%)

70

50–70

Lymphocytes (%)

24.9

20–40

Hemoglobin (g/L)

92

120–140

Hematocrit (%)

28.2

35–45

Reticulocyte (%)

3.09

0.5–1.5

Platelets (× 109 /L)

76

100–300

Hypersensitive C-reactive protein (mg/L)

< 0.5

< 0.5

Erythrocyte Sedimentation Rate (mm/h)

18

0–20

D-dimer (mg/L)

0,58

< 0.3

Prothrombin activity (%)

59.5

75–100

Prothrombin time (sec)

14.1

12–14

Blood triglyceride (mmol/L)

6.01

< 1.13

Immunoassay

Immunoglobulin A (g/L)

1.44

0.29–2.7

Immunoglobulin E (U/L)

21

< 100

Immunoglobulin G (g/L)

8.61

7–16.5

Immunoglobulin M (g/L)

1

0.5–2.6

Serum complement3 (g/L)

0.99

0.9–1.8

Serum complement4 (g/L)

0.15

0.1–0.4

Coombs test

Negative

Negative

ADAMTS13 activity (%)

< 2.5

68–130

Hepatic analysis

Total bilirubin (μmol/L)

14.4

3.4–17.1

Direct bilirubin (μmol/L)

3.8

0–6.8

Alanine aminotransferase (U/L)

13

7–40

Aspartate transaminase (U/L)

26

13–35

Renal analysis

Urea (mmol/L)

14.41

2.6–8.8

Creatinine (μmol/L)

184

41–81

Uric acid (μmol/L)

596

119–327

Urinalysis

Qualitative protein analysis

+

Negative

Cerebrospinal fluid analysis

Total cerebrospinal fluid protein (mg/L)

245

200–400

Cerebrospinal Fluid Chloride (mmol/L)

130

117–127

Cerebrospinal fluid glucose (mmol/L)

3.22

2.8–4.5

Myocardial enzymes

Creatine Kinase (U/L)

162

25–170

Lactate dehydrogenase (U/l)

531

150–450

Cardiac troponin I (pg/mL)

30.49

< 200

  1. Bold represents the patient had an abnormality in this indicator